This specialty pharmaceutical and medical device company has seen one positive estimate revision in the last 30 days. The Zacks Consensus Estimate has also moved higher over the same period. This implies solid trading potential for the company. So make sure to keep an eye on this stock going forward to see if yesterday’s sharp climb can turn into more strength down the road.
Delcath Systems currently holds a Zacks Rank #1 (Strong Buy) while its Earnings ESP is 0.00%.
Investors interested in the medical instruments industry can also consider other stocks like Cynosure, Inc. (CYNO), Syneron Medical Ltd. (ELOS) and Globus Medical, Inc. (GMED). All three stocks sport the same Zacks Rank as Delcath Systems.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
DELCATH SYSTEMS INC (DCTH): Free Stock Analysis Report
CYNOSURE INC (CYNO): Free Stock Analysis Report
SYNERON MEDICAL LTD ORD (ELOS): Free Stock Analysis Report
GLOBUS MEDICAL INC (GMED): Free Stock Analysis Report
Zacks Investment Research
- Health Care Industry